Elbehiry Ayman, Marzouk Eman, Abalkhail Adil, Edrees Husam M, Ellethy Abousree T, Almuzaini Abdulaziz M, Ibrahem Mai, Almujaidel Abdulrahman, Alzaben Feras, Alqrni Abdullah, Abu-Okail Akram
Department of Public Health, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah 51452, Saudi Arabia.
Department of Physiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.
Microorganisms. 2025 Jul 6;13(7):1592. doi: 10.3390/microorganisms13071592.
The intersection of microbial food safety and antimicrobial resistance (AMR) represents a mounting global threat with profound implications for public health, food safety, and sustainable development. This review explores the complex pathways through which foodborne pathogens-such as spp., (), (), and spp.-acquire and disseminate resistance within human, animal, and environmental ecosystems. Emphasizing a One Health framework, we examine the drivers of AMR across sectors, including the misuse of antibiotics in agriculture, aquaculture, and clinical settings, and assess the role of environmental reservoirs in sustaining and amplifying resistance genes. We further discuss the evolution of surveillance systems, regulatory policies, and antimicrobial stewardship programs (ASPs) designed to mitigate resistance across the food chain. Innovations in next-generation sequencing, metagenomics, and targeted therapeutics such as bacteriophage therapy, antimicrobial peptides (AMPs), and CRISPR-based interventions offer promising alternatives to conventional antibiotics. However, the translation of these advances into practice remains uneven, particularly in low- and middle-income countries (LMICs) facing significant barriers to diagnostic access, laboratory capacity, and equitable treatment availability. Our analysis underscores the urgent need for integrated, cross-sectoral action-anchored in science, policy, and education-to curb the global spread of AMR. Strengthening surveillance, investing in research, promoting responsible antimicrobial use, and fostering global collaboration are essential to preserving the efficacy of existing treatments and ensuring the microbiological safety of food systems worldwide.
微生物食品安全与抗菌药物耐药性(AMR)的交叉领域构成了日益严重的全球威胁,对公共卫生、食品安全和可持续发展具有深远影响。本综述探讨了食源性病原体(如 属、 ( )、 ( )和 属)在人类、动物和环境生态系统中获得和传播耐药性的复杂途径。我们强调“同一个健康”框架,研究跨部门AMR的驱动因素,包括农业、水产养殖和临床环境中抗生素的滥用,并评估环境储存库在维持和放大耐药基因方面的作用。我们还讨论了旨在减轻整个食物链耐药性的监测系统、监管政策和抗菌药物管理计划(ASP)的演变。下一代测序、宏基因组学以及噬菌体疗法、抗菌肽(AMP)和基于CRISPR的干预等靶向治疗方面的创新为传统抗生素提供了有前景的替代方案。然而,这些进展转化为实际应用的情况仍然参差不齐,特别是在面临诊断获取、实验室能力和公平治疗可及性重大障碍的低收入和中等收入国家(LMIC)。我们的分析强调迫切需要以科学、政策和教育为基础采取综合、跨部门行动,以遏制AMR的全球传播。加强监测、投资研究、促进负责任的抗菌药物使用以及促进全球合作对于保持现有治疗方法的有效性和确保全球食品系统的微生物安全性至关重要。